Clinical evaluation in treatment of oral lichen planus with topical fluocinolone acetonide: A 2-year follow-up

Journal of Oral Pathology and Medicine

Volumn 32, Issue 6, 2003, Pages 315-322

  Thongprasom, K ^a   Luengvisut, P ^a   Wongwatanakij, A ^a   Boonjatturus, C ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Candidiasis; Fluocinolone acetonide; Oral lichen planus

Indexed keywords

FLUOCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; RANDOMIZED CONTROLLED TRIAL; REMISSION; STATISTICAL SIGNIFICANCE; THRUSH; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; CANDIDIASIS, ORAL; CARBOXYMETHYLCELLULOSE; DRUG COMBINATIONS; FEMALE; FLUOCINOLONE ACETONIDE; GLUCOCORTICOIDS; HUMANS; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEX RATIO;

EID: 0038127025     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2003.00130.x     Document Type: Article

References (56)

1. Scully C, Beyli M, Ferreiro MC, et al. Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 1998; 9: 86-122.
2. Eversole LR. Immunopathogenesis of oral lichen planus and recurrent aphthous stomatitis. Semin Cutan Med Surg 1997; 16: 284-94.
3. Mignogna MD, Lo Muzio L, Lo Russo L, et al. Oral lichen planus: different clinical features in HCV-positive and HCV-negative patients. Int J Dermatol 2000; 39: 134-9.
4. Nagao Y, Sata M, Noguchi S, et al. Detection of hepatitis C virus in oral lichen planus and cancer. J Oral Pathol Med 2000; 29: 259-66.
5. Del Olmo JA, Pascual I, Bagan JV, et al. Prevalence of hepatitis C virus in patients with lichen planus of the oral cavity and chronic liver disease. Eur J Oral Sci 2000; 108: 378-82.
6. Guijarro GB, Lopez SAF, Hernandez VG. Presence of lichen planus during a course of interferon alpha-2a therapy for a viral chronic C hepatitis. Med Oral 2001; 6: 358-63.
7. Lozada-Nur F, Miranda C. Oral lichen planus: topical and systemic therapy. Semin Cutan Med Surg 1997; 16: 295-300.
8. Lu SY, Chen WJ, Eng HL. Dramatic response to levamisole and low-dose prednisolone in 23 patients with oral lichen planus: a 6-year prospective follow-up study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 80: 705-9.
9. Lozada-Nur F, Miranda C, Maliksi R. Double-blind clinical trial of 0.05% clobetasol propionate (corrected from propionate) ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol 1994; 77: 598-604.
10. Thongprasom K, Luangjarmekorn L, Sererat T, Taweesap W. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med 1992; 21: 456-8.
11. Woo TY. Systemic isotretinoin treatment of oral and cutaneous lichen planus. Cutis 1985; 35: 385-93.
12. Sloberg K, Hersle K, Mobecken H, Thilander H. Severe oral lichen planus: remission and maintenance with vitamin A analogues. J Oral Pathol 1983; 12: 473-7.
13. Gorsky M, Raviv M. Efficacy of etretinate (Tigason) in symptomatic oral lichen planus. Oral Surg Oral Med Oral Pathol 1992; 73: 52-5.
14. Ferguson MM, Simpson NB, Hammersly N. The treatment of erosive lichen planus with a retinoid-etretinate. Oral Surg Oral Med Oral Pathol 1984; 58: 283-7.
15. Regezi JA, Ellis CN, Stewart JCB, et al. Histologic changes associated with the topical use of isotretinoin on oral lichen planus. Oral Surg Oral Med Oral Pathol 1986; 61: 479-84.
16. Buajeeb W, Kraivaphan P, Pobrurksa C. Efficacy of topical retinoic acid compared with topical fluocinolone acetonide in the treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83: 21-5.
17. Pacor ML, Biasi D, Urbani G, et al. The efficacy of cyclosporin for topical use in oral lichen planus. Minerva Stomatol 1994; 43: 129-32.
18. Eisen D, Ellis CN. Topical cyclosporine for oral mucosal disorders. J Am Acad Dermatol 1990; 23: 1259-63.
19. Voute AB, Schulten EA, Langendijk PN, et al. Cyclosporin A in an adhesive base for treatment of recalcitrant oral lichen planus. Oral Surg Oral Med Oral Pathol 1994; 78: 437-41.
20. Jungell P, Malmstrom M. Cyclosporin A mouthwash in the treatment of oral lichen planus. Int J Oral Maxillofac Surg 1996; 25: 60-2.
21. Sieg P, Von Domarus H, Von Zitzewitz V, et al. Topical cyclosporin in oral lichen planus: a controlled, randomized, prospective trial. Br J Dermatol 1995; 132: 790-4.
22. Epstein JB, Truelove EL. Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions: an open label clinical trial. Oral Surg Oral Med Oral Pathol 1996; 82: 532-6.
23. Rozycki TW, Rogers RS, III, Pittelkow MR, et al. Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients. J Am Acad Dermatol 2002; 46: 27-34.
24. Kaliakatsou F, Hodgson TA, Lewsey JD, et al. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 2002; 46: 35-41.
25. Morrison L, Kratochvil FJ, III, Gorman A. An open trial of topical tacrolimus for erosive oral lichen planus. J Am Acad Dermatol 2002; 47: 617-20.
26. Lener EV, Brieva J, Schachter M, et al. Successful treatment of erosive lichen planus with topical tacrolimus. Arch Dermatol 2001; 137: 419-22.
27. Hernandez G, Jimenez C, Arriba L, et al. Resolution of oral ulcerations after decreasing the dosage of tacrolimus in a liver transplantation recipient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 521-31.
28. Thorn JJ, Holmstrup P, Rindum J, et al. Course of various clinical forms of oral lichen planus: a prospective follow-up study of 611 patients. J Oral Pathol 1988; 77: 213-8.
29. Silverman S, Jr, Gorsky M, Lozada-Nur F, et al. A prospective study of findings and management in 214 patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 1991; 72: 665-70.
30. Lozada-Nur F, Miranda C. Oral lichen planus: epidemiology, clinical characteristics, and associated diseases. Semin Cutan Med Surg 1997; 16: 273-7.
31. Lodi G, Porter SR. Hepatitis C virus infection and lichen planus: a short review. Oral Dis 1997; 3: 77-81.
32. Figueiredo LC, Carrilho FJ, de Andrade HF, Jr, et al. Oral lichen planus and hepatitis C virus infection. Oral Dis 2002; 8: 42-6.
33. Harris D, Robinson JR. Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci 1992; 81: 1-9.
34. Pimlot SJ, Addy M. Evaluation of a method to study the uptake of prednisolone sodium phosphate from different oral mucosal sites. Oral Surg Oral Med Oral Pathol 1985; 60: 35-7.
35. Thornhill MH. Immune mechanisms in oral lichen planus. Acta Odontol Scand 2001; 59: 174-7.
36. Thomas DW, Stephens P, Stephens M, et al. T-cell receptor V beta usage by lesional lymphocytes in oral lichen planus. J Oral Pathol Med 1997; 26: 105-9.
37. Zhou XJ, Savage NW, Sugerman PB, et al. TCR Vb gene expression in lesional T-lymphocyte cell lines in oral lichen planus. Oral Dis 1996; 2: 295-8.
38. Vincent SD, Fotos PG, Baker KA, et al. Oral lichen planus: the clinical, historical, and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol 1990; 70: 165-71.
39. Vincent SD, Lilly GE, Baker KA. Clinical, historic, and therapeutic features of cicatricial pemphigoid: a literature review and open therapeutic trial with corticosteroids. Oral Surg Oral Med Oral Pathol 1993; 76: 453-9.
40. Carbone M, Carrozzo M, Broccoletti R, et al. A topical treatment of atrophic-erosive oral lichen planus with fluocinonide in a bioadhesive gel, chlorhexidine and miconazole gel: a totally open trial. Minerva Stomatol 1996; 45: 61-8.
41. Epstein JB, Komiyama K, Duncan D. Oral topical steroids and secondary oral candidiasis. J Oral Med 1986; 41: 223-7.
42. Krogh P, Holmstrup P, Thorn JJ, et al. Yeast species and biotypes associated with oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol 1987; 63: 48-54.
43. Hatchuel DA, Peters E, Lemmer J, et al. Candidal infection in oral lichen planus. Oral Surg Oral Med Oral Pathol 1990; 70: 172-5.
44. Eisen D. The therapy of oral lichen planus. Crit Rev Oral Biol Med 1993; 4: 141-58.
45. Carbone M, Carrozzo M, Conrotto D, et al. Topical treatment of atrophic-erosive oral lichen planus with clobetasol in bioadhesive gel as well as chlohexidine and miconazole in oral gel. Minerva Stomatol 1997; 46: 423-8.
46. Chainani-Wu N, Silverman S, Jr, Lozada-Nur F, et al. Oral lichen planus: patient profile, disease progression and treatment responses. JADA 2001; 132: 901-9.
47. Sleeper HR. Intralesional and sublesional injection of triamcinolone acetonide for oral lichen planus. Yale J Biol Med 1967; 40: 164-5.
48. Zegarelli D. Topical intralesional steroid therapy of oral lichen planus. NY State Dent 1980; 46: 432.
49. Camisa C, Rinder JM. Diseases of the oral mucous membranes. Curr Probl Dermatol 1996; 8: 43-96.
50. Porter SR, Scully C, Eveson JW. The efficacy of topical cyclosporin in the management of desquamative gingivitis due to lichen planus. Br J Dermatol 1993; 129: 753-5.
51. Seoane J, Vazquez J, Romero MA, et al. Photochemotherapy in the treatment of oral erosive lichen planus. Acta Otorrinolaringol Esp 1997; 48: 251-3.
52. Kuusilehto A, Lehtinen R, Happonen RP, et al. An open clinical trial of a new mouth PUVA variant in the treatment of oral lichenoid lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 84: 502-5.
53. Lundquist G, Forsgren H, Gajecki M, et al. Photochemotherapy of oral lichen planus: a controlled study. Oral Surg Oral Med Oral Pathol 1995; 79: 554-8.
54. Lindelof B, Sigurgersson B, Tegner E, et al. PUVA and cancer: a large-scale epidemiologic study. Lancet 1991; 338: 91-3.
55. Vartdal F. Genetic background for immune-mediated diseases. Acta Odontol Scand 2001; 59: 212-5.
56. Scully C, Eisen D, Carrozo M. Management of oral lichen planus. Am J Clin Dermatol 2000; 1: 287-306.